Clinical trial

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in…

NCT00003211 · St. Jude Children's Research Hospital, Other · Completed

Key facts

NCT number NCT00003211
Title Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
Official title Treatment of Newly Diagnosed Medulloblastoma and Supratentorial PNET in Patients At Least 3 Years With a Phase II Topotecan Window (High-Risk Patients Only), Risk-Adapted Radiation Therapy, and Dose-Intensive Chemotherapy With Peripheral Blood Stem Cell Support
Lead sponsor St. Jude Children's Research Hospital, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Brain and Central Nervous System Tumors
Intervention type Biological, Drug, Procedure, Radiation
Interventions filgrastim, amifostine trihydrate, cisplatin, cyclophosphamide, vincristine sulfate, peripheral blood stem cell transplantation, radiation therapy
Enrollment 94
Start date Oct 1, 1996
Primary completion Jun 1, 2007
Completion Jun 1, 2007
First posted Jul 9, 2003
Last update posted Nov 7, 2012
Countries Australia, United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies